answer text |
<p>In the United Kingdom, strict regulatory controls govern the sale, supply, manufacture,
distribution and advertising of medicinal products.</p><p> </p><p>Although no fatalities
in the UK have been attributed to a falsified medicine sourced from the UK regulated
supply chain, the potential threat to patient health is recognised and taken seriously
across Government.</p><p> </p><p>No incidents of a falsified medicine reaching a patient
through the regulated supply chain have been recorded since 2009. However, if such
an incidence occurs, the Medicines and Healthcare products Regulatory Agency (MHRA)
has strategies in place to ensure immediate and proportionate action is taken, including
a thorough investigation and withdrawal of the medicines from circulation.</p><p>
</p><p>The majority of illegal activity involving medicines takes place online and
MHRA efforts to tackle this are focussed both on the supply and demand. The MHRA has
arrangements in place with Border Force to seize illegally imported medicines on entry
into the UK and works with the Internet service industry to close websites operating
outside of legal requirements.</p>
|
|